Day: May 25, 2021

R1 RCM Announces Commencement of Secondary Offering by Selling Stockholders

R1 RCM Announces Commencement of Secondary Offering by Selling Stockholders

CHICAGO, May 25, 2021 (GLOBE NEWSWIRE) — R1 RCM Inc. (“R1 RCM” or the “Company”) (NASDAQ: RCM) announced the commencement of an underwritten offering of an aggregate of 15,000,000 shares of its common stock by selling stockholders. The selling stockholders are TCP-ASC ACHI Series LLLP (“TCP-ASC”), a Delaware series limited liability limited partnership jointly owned by Ascension Health Alliance and investment funds affiliated with TowerBrook Capital Partners, L.P., and Joseph Flanagan, the President and Chief Executive Officer of the Company. The underwriters will have a 30-day option to purchase up to an additional 2,250,000 shares of common stock from TCP-ASC. R1 RCM is not selling any shares in the offering and will not receive any of the proceeds from the sale of common stock by the selling stockholders. Barclays, J.P. Morgan,...

Continue reading

TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

TFF Pharmaceuticals to Participate in Jefferies Virtual Healthcare Conference

AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that management will present a corporate overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 11:30am EST. To register in advance for the corporate presentation, sign up here. Replay Link: A replay will be accessible on the Events & Presentations page of the Investors section on the Company’s website at https://ir.tffpharma.com/events-and-presentations/events About TFF Pharmaceuticals TFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products...

Continue reading

AMC Networks Inc. Announces Change to Location and Format of 2021 Annual Meeting of Stockholders

AMC Networks Inc. Announces Change to Location and Format of 2021 Annual Meeting of Stockholders

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (Nasdaq:AMCX) today announced that it will be holding its Annual Meeting of Stockholders (the “Annual Meeting”) in person at the J.P. Morgan Club at the Madison Square Garden Arena, located on Seventh Avenue between West 31st Street and West 33rd Street, New York, New York 10001. As previously announced, the meeting will be held on Wednesday, June 16, 2021 at 10:00 a.m. Eastern Daylight Time. Stockholders will not be able to attend the Annual Meeting virtually. There is no change to the items of business to be addressed at the Annual Meeting, which are described in the proxy materials previously made available to the Company’s stockholders. As described in those proxy materials, the Board of Directors fixed the close of business on April...

Continue reading

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Conference. Jon Heimer, CEO and Oskar Hjelm, CFO are scheduled to participate in a virtual fireside chat on Wednesday, June 9th, 2021 at 8:50 a.m. ET.  A live and archived webcast will be available on the “Investors” section of the Olink website at investors.olink.com/investor-relations. About Olink Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical...

Continue reading

21Vianet Group, Inc. Reports Unaudited First Quarter 2021 Financial Results

21Vianet Group, Inc. Reports Unaudited First Quarter 2021 Financial Results

BEIJING, May 25, 2021 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and cloud-neutral Internet data center services provider in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. The Company will hold a conference call at 8:00 P.M. on Tuesday, May 25, 2021, U.S. Eastern Time to discuss the financial results. Dial-in details are provided at the end of this release. First Quarter 2021 Financial Highlights Net revenues increased by 27.1% to RMB1.39 billion (US$211.7 million) from RMB1.09 billion in the same period of 2020. Adjusted cash gross profit (non-GAAP) increased by 45.1% to RMB605.3 million (US$92.4 million) from RMB417.1 million in the same period of 2020. Adjusted cash gross margin (non-GAAP)...

Continue reading

Ed McKay appointed as Executive Vice President and Chief Operating Officer for Shenandoah Telecommunications Company

Ed McKay appointed as Executive Vice President and Chief Operating Officer for Shenandoah Telecommunications Company

EDINBURG, Va., May 25, 2021 (GLOBE NEWSWIRE) — Shenandoah Telecommunications Company (“Shentel” or the “Company”) (NASDAQ:SHEN) announced today that Edward “Ed” H. McKay will be appointed to the role of Executive Vice President and Chief Operating Officer. Mr. McKay will be responsible for the leadership of the Company’s entire integrated broadband business, including Shentel Cable, Shentel Business, Glo Fiber and Beam brands, and the Company’s tower portfolio. Mr. McKay is a twenty-five year veteran of the telecommunications industry, with the past seventeen years as part of Shentel’s management team. He most recently served the Company as Senior Vice President, Engineering & Operations, where he has been responsible for delivering on Shentel’s growth strategy for fiber and fixed wireless broadband businesses, while also...

Continue reading

Ashland announces strategic review of its performance adhesives business unit and enhanced focus on growth in high-value ingredients portfolio

Ashland announces strategic review of its performance adhesives business unit and enhanced focus on growth in high-value ingredients portfolio

WILMINGTON, Del., May 25, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH), today announced a strategic review of its performance adhesives business unit. Ashland intends to evaluate all options with respect to the business unit, including a potential sale. The decision is consistent with the company’s strategy to grow its integrated additive ingredients portfolio focused on its leadership positions in its core pharma, personal care, and coatings businesses. “Ashland’s performance adhesives business unit has demonstrated exceptional financial performance with a strong and dedicated business team who excel at solutions in key niche markets,” said Guillermo Novo, chairman and chief executive officer, Ashland. “The business has valuable products with differentiating performance for customers across a variety of applications...

Continue reading

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Olink to present at the Goldman Sachs 42nd Annual Global Healthcare Conference

UPPSALA, Sweden, May 25, 2021 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that it will be participating in the Goldman Sachs 42nd Annual Global Healthcare Conference. Jon Heimer, CEO and Oskar Hjelm, CFO are scheduled to participate in a virtual fireside chat on Wednesday, June 9th, 2021 at 8:50 a.m. ET.   A live and archived webcast will be available on the “Investors” section of the Olink website at investors.olink.com/investor-relations. About OlinkOlink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical...

Continue reading

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)

Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacin Lefamulin was generally safe and well-tolerated in Chinese adults Greater Chinese rights to lefamulin will be held by Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., a wholly-owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd. HONG KONG, SHANGHAI, China, SUZHOU, China and DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) — Sinovant Sciences, a Chinese biopharmaceutical company dedicated to conducting innovative biomedical R&D in China, and Nabriva Therapeutics (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective...

Continue reading

Physical Rehabilitation Network Acquires California-Based Rocklin Physical Therapy

Physical Rehabilitation Network Acquires California-Based Rocklin Physical Therapy

Carlsbad, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Physical Rehabilitation Network (PRN), a leading physical therapy provider and practice management organization, today announced further expansion in California and its first-ever clinic in Sacramento, with its acquisition of Rocklin Physical Therapy, Inc. The addition of Rocklin Physical Therapy elevates PRN’s California footprint to 51 clinics and national clinic count to 156 locations. Under this new partnership, PRN will acquire Rocklin Physical Therapy’s sole outpatient physical therapy clinic, which boasts a spacious 6,000 square foot treatment area. Rocklin’s team of experts provide a combination of traditional and highly specialized physical therapy services ranging from manual therapy, orthopedic care, and sports injury management to worksite injury prevention and management.  “We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.